Suppr超能文献

无定形药物再结晶的主要预测参数β弛豫的玻璃化转变温度。

Glass-Transition Temperature of the β-Relaxation as the Major Predictive Parameter for Recrystallization of Neat Amorphous Drugs.

机构信息

Department of Pharmacy , University of Copenhagen , Universitetsparken 2 , 2100 Copenhagen , Denmark.

Department of Chemical Engineering and Biotechnology , University of Cambridge , Philippa Fawcett Drive , Cambridge , CB3 0AS , United Kingdom.

出版信息

J Phys Chem B. 2018 Mar 15;122(10):2803-2808. doi: 10.1021/acs.jpcb.7b10105. Epub 2018 Mar 2.

Abstract

Recrystallization of amorphous drugs is currently limiting the simple approach to improve solubility and bioavailability of poorly water-soluble drugs by amorphization of a crystalline form of the drug. In view of this, molecular mobility, α-relaxation and β-relaxation processes with the associated transition temperatures T and T, was investigated using dynamic mechanical analysis (DMA). The correlation between the transition temperatures and the onset of recrystallization for nine amorphous drugs, stored under dry conditions at a temperature of 296 K, was determined. From the results obtained, T does not correlate with the onset of recrystallization under the experimental storage conditions. However, a clear correlation between T and the onset of recrystallization was observed. It is shown that at storage temperature below T, amorphous nifedipine retains its amorphous form. On the basis of the correlation, an empirical correlation is proposed for predicting the onset of recrystallization for drugs stored at 0% RH and 296 K.

摘要

目前,无定形药物的再结晶限制了通过药物晶型的无定形化来提高低水溶性药物溶解度和生物利用度的简单方法。有鉴于此,使用动态力学分析(DMA)研究了分子迁移率、α松弛和β松弛过程以及相关的转变温度 T 和 T。确定了在 296 K 温度下干燥条件下储存的九种无定形药物的转变温度与再结晶起始之间的相关性。从获得的结果来看,T 在实验储存条件下与再结晶起始没有相关性。然而,在 T 以下观察到 T 和再结晶起始之间存在明显的相关性。结果表明,在储存温度低于 T 时,无定形硝苯地平保持其无定形形式。基于相关性,提出了一种用于预测在 0%RH 和 296 K 下储存的药物再结晶起始的经验相关性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验